electroCore, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ECOR Nasdaq 3841 https://www.electrocore.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for electroCore, Inc.

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Attention and Working Memory in Patients with Post Traumatic Stress Disorder (PTSD) - Sep 27th, 2023 12:00 pm
electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology - Sep 26th, 2023 12:00 pm
iAccess Alpha Best Ideas from the Buyside Virtual Conference - Sep 26th-27th 2023 - Sep 25th, 2023 12:30 pm
electroCore to Participate in the LD Micro Main Event XVI Conference - Sep 25th, 2023 12:00 pm
electroCore to Present at iAccess Alpha’s – Top 10 Best Ideas from the Buyside Virtual Conference - Sep 21st, 2023 12:00 pm
electroCore to Participate in the H.C. Wainwright 25th Annual Global Investment Conference - Sep 7th, 2023 12:00 pm
electroCore Announces Dismissal of All Litigation Related to Its 2018 Initial Public Offering - Aug 23rd, 2023 12:00 pm
ECOR: 2Q:23 Revenues Impress - Aug 11th, 2023 10:46 am
Q2 2023 electroCore, Inc. Earnings Call - Aug 10th, 2023 11:39 am
electroCore Announces Second Quarter 2023 Financial Results - Aug 9th, 2023 8:05 pm
electroCore to Announce Second Quarter Financial Results on Wednesday, August 9 - Aug 1st, 2023 12:00 pm
electroCore, Inc. Announces $8.145 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules - Jul 31st, 2023 1:29 pm
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD) - Jul 25th, 2023 12:00 pm
electroCore Expands Intellectual Patent Portfolio for nVNS Technology - Jul 18th, 2023 12:00 pm
ECOR: Adding Reliefband to the Portfolio - Jul 17th, 2023 10:03 am
electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC - Jul 13th, 2023 12:00 pm
electroCore Provides Select Second Quarter 2023 Financial Guidance - Jul 11th, 2023 12:00 pm
gammaCore™ Non-Invasive Vagal Nerve Stimulation Selected for Study Funded by the National Football League (NFL) and National Football League Players Association (NFLPA) on Alleviating Concussion Symptoms - Jul 6th, 2023 12:00 pm
TAC-STIM™ Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project - Jun 27th, 2023 12:00 pm
electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC - Jun 14th, 2023 12:00 pm